Are Analysts Bearish Alcobra Ltd. (NASDAQ:ADHD) After Last Week?

December 7, 2017 - By Kurt Siggers

 Are Analysts Bearish Alcobra Ltd. (NASDAQ:ADHD) After Last Week?

Alcobra Ltd. (NASDAQ:ADHD) Ratings Coverage

Among 7 analysts covering Alcobra (NASDAQ:ADHD), 2 have Buy rating, 1 Sell and 4 Hold. Therefore 29% are positive. Alcobra had 19 analyst reports since August 9, 2015 according to SRatingsIntel. On Thursday, September 29 the stock rating was downgraded by Cantor Fitzgerald to “Hold”. As per Thursday, September 29, the company rating was downgraded by Oppenheimer. TH Capital maintained the stock with “Buy” rating in Friday, August 14 report. The company was maintained on Wednesday, May 31 by Roth Capital. The company was initiated on Thursday, February 18 by Jefferies. Cantor Fitzgerald initiated the stock with “Buy” rating in Tuesday, June 7 report. WBB Securities upgraded Alcobra Ltd. (NASDAQ:ADHD) on Monday, October 9 to “Speculative Buy” rating. The stock of Alcobra Ltd. (NASDAQ:ADHD) earned “Outperform” rating by Oppenheimer on Monday, January 25. Jefferies downgraded Alcobra Ltd. (NASDAQ:ADHD) on Wednesday, January 18 to “Hold” rating. Barclays Capital initiated the stock with “Equal-Weight” rating in Monday, August 1 report. Below is a list of Alcobra Ltd. (NASDAQ:ADHD) latest ratings and price target changes.

09/10/2017 Broker: WBB Securities Old Rating: Hold New Rating: Speculative Buy New Target: $2 Upgrade
29/09/2017 Broker: Roth Capital Rating: Hold New Target: $1.0 Downgrade
11/08/2017 Broker: Roth Capital Rating: Buy New Target: $4.0000 Maintain
12/06/2017 Broker: Jefferies Rating: Hold New Target: $1.2500 Maintain

The stock increased 4.29% or $0.42 during the last trading session, reaching $10.22. About 1.11M shares traded. Alcobra Ltd. (NASDAQ:ADHD) has declined 74.73% since December 7, 2016 and is downtrending. It has underperformed by 91.43% the S&P500.

More notable recent Alcobra Ltd. (NASDAQ:ADHD) news were published by: which released: “Arcturus Therapeutics, Inc. to Present at the Chardan Gene Therapy Conference” on October 06, 2017, also with their article: “BRIEF-Alcobr, Arcturus Therapeutics agree to merge” published on September 27, 2017, published: “Arcturus Therapeutics and Synthetic Genomics Announce Strategic Alliance to …” on October 31, 2017. More interesting news about Alcobra Ltd. (NASDAQ:ADHD) were released by: and their article: “Arcturus Therapeutics Announces Completion of Merger with Alcobra Ltd. and …” published on November 16, 2017 as well as‘s news article titled: “Arcturus Therapeutics Announces Presentations at Conferences in November” with publication date: October 26, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.